MONOCYTE FUNCTION IN HODGKIN'S DISEASEHOLM G; BJOERKHOLM M; JOHANSSON B et al.1982; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1982; VOL. 47; NO 1; PP. 162-168; BIBL. 31 REF.Article

EFFECTS OF IMMUNOTHERAPY AND CHEMOTHERAPY ON IMMUNOCOMPETENCE. A STUDY OF PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA IN REMISSIONUDEN AM; LINDEMALM C; PAULI C et al.1978; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1978; VOL. 4; NO 4; PP. 239-245; BIBL. 2 P.Article

Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphomaENBLAD, G; GLIMELIUS, B; HAGBERG, H et al.Acta oncologica (Stockholm). 1990, Vol 29, Num 3, pp 297-301, issn 0284-186XArticle

CELL-MEDIATED IMMUNITY IN HUMAN ACUTE MYELOBLASTIC LEUKEMIA: LYMPHOCYTE STIMULATION BY AUTOLOGOUS LEUKEMIC AND NONLEUKEMIC MYOBLASTSPAULI C; VANKY F; HAST R et al.1978; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1978; VOL. 5; NO 1; PP. 1-10; BIBL. 1 P.Article

T CELLS IN MONOCLONAL GAMMOPATHIESMELLSTEDT H; HOLM G; PETTERSSON D et al.1982; SCAND. J. HAEMATOL.; ISSN 0036-553X; DNK; DA. 1982; VOL. 29; NO 1; PP. 57-64; BIBL. 32 REF.Article

BLOOD AND LYMPH NODE T-LYMPHOCYTE SUBSETS IN NON-HODGKIN LYMPHOMAS = LES SOUS-POPULATIONS DE LYMPHOCYTE T DU SANG ET DES GANGLIONS DANS LES LYMPHOMES NON HODGKINIENSLINDEMALM C; MELLSTEDT H; BIBERFELD P et al.1983; SCANDINAVIAN JOURNAL OF HAEMATOLOGY; ISSN 0036-553X; DNK; DA. 1983; VOL. 30; NO 1; PP. 68-78; ABS. ENG; BIBL. 2 P.; GRAPHArticle

ANTIBODY-DEPENDENT HAEMOLYTIC ACTIVITY OF HUMAN LEUKAEMIC CELLSHOLM G; BJOERKHOLM M; BOETTIGER B et al.1980; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1980; VOL. 42; NO 1; PP. 121-126; BIBL. 14 REF.Article

Mitoxantrone, etoposide, cytarabine and prednisone as salvage therapy for refractory non-Hodgkin lymphoma (NHL) and alternated with CHOP in previously untreated patients with NHLMERK, K; IDESTROÊM, K; JOHANSSON, B et al.European journal of haematology. 1991, Vol 46, Num 1, pp 33-37, issn 0902-4441, 5 p.Article

Clonal immunoglobulin gene rearrangements in primary mediastinal clear cell lymphomasBRANDTER, L. B; SMITH, C. I. E; HAMMARSTROM, L et al.Leukemia. 1989, Vol 3, Num 2, pp 122-129, issn 0887-6924Article

Blood lymphocyte characteristics as predictors of prognosis in chronic lymphocytic leukemia of B-cell typeKIMBY, E; MELLSTEDT, H; NILSSON, B et al.Hematological oncology. 1988, Vol 6, Num 1, pp 47-55, issn 0278-0232Article

Correlation of immunophenotype to morphology in unfavourable non-Hodgkin lymphoma = Corrélation de l'immunophénotype avec la morphologie des lymphomes non hodgkiniens de mauvais pronosticCHRISTENSSON, B; LINDEMALM, C; JOHANSSON, B et al.Acta pathologica, microbiologica et immunologica Scandinavica. Section A. Pathology. 1983, Vol 91, Num 6, pp 425-433, issn 0108-0164Article

Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphomaCHRISTENSSON, B; LINDEMALM, C; JOHANSSON, B et al.Leukemia research. 1989, Vol 13, Num 4, pp 307-314, issn 0145-2126Article

CHOP vs MEV for the treatment of non-Hodgkin's lymphoma of unfavourable histopathology: a randomized clinical trialHAGBERG, H; BJORKHOLM, M; GLIMELIUS, B et al.European journal of cancer & clinical oncology. 1985, Vol 21, Num 2, pp 175-179, issn 0277-5379Article

A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomasLINDEMALM, C; CHRISTENSSON, B; JOHANSSON, B et al.Acta pathologica, microbiologica et immunologica Scandinavica. Section A. Pathology. 1983, Vol 91, Num 6, pp 435-443, issn 0108-0164Article

Mitogen induced blood lymphocyte DNA synthesis as a prognostic indicator in patients with non-Hodgkin's lymphomas in clinical remission = L'induction par mitogène de la synthèse de l'ADN des lymphocytes périphériques comme facteur pronostique chez les sujets atteints de lymphomes non hodgkiniens en rémission cliniqueLINDEMALM, C. S; BJÖRKHOLM, M; HOLM, G et al.Acta radiologica. Oncology. 1983, Vol 22, Num 6, pp 455-459, issn 0349-652XArticle

Human herpesvirus-6 (HHV-6, HBLV) in sarcoidosis and lymphoproliferative disordersBIBERFELD, P; PETREN, A.-L; EKLUND, A et al.Journal of virological methods. 1988, Vol 21, Num 1-4, pp 49-59, issn 0166-0934Conference Paper

Immunodeficiency and prognosis in patients with non-Hodgkin's lymphomasLINDEMALM, C; BIBERFELD, P; BJORKHOLM, M et al.Acta radiologica. Oncology. 1985, Vol 24, Num 2, pp 159-165, issn 0349-652XArticle

Epstein-Barr virus-associated antibody pattern in untreated non-Hodgkin lymphoma patients: relationship to clinical variables and lymphocytes functions = Titre des anticorps associés au virus d'Epstein-Barr chez les sujets ayant un lymphome non hodgkinien non traité. Corrélations aux variables cliniques et aux fonctions lymphocytairesLINDEMALM, C; BIBERFELD, P; BJORKHOLM, M et al.International journal of cancer. 1983, Vol 32, Num 6, pp 675-682, issn 0020-7136Article

Blood clonal B cell excess (CBE) at diagnosis in patients with non-Hodgkin lymphoma (NHL): relation to clinical stage, histopathology and response to treatmentLINDEMALM, C; MELLSTEDT, H; NILSSON, B et al.European journal of cancer & clinical oncology. 1987, Vol 23, Num 6, pp 749-753, issn 0277-5379Article

Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas = Caractérisation des phénotypes des cellules malignes et non malignes dans les lymphomes non hodgkiniens à haute malignitéPORWIT-KSIAZEK, A; CHRISTENSSON, B; LINDEMALM, C et al.International journal of cancer. 1983, Vol 32, Num 6, pp 667-674, issn 0020-7136Article

Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma : long-lasting, complete remissions can be inducedRAGNHAMMAR, P; FAGERBERG, J; FRÖDIN, J.-E et al.International journal of cancer. 1993, Vol 53, Num 5, pp 751-758, issn 0020-7136Article

Blood clonal B cell excess at diagnosis in multiple myeloma: relation to prognosisOSTERBORG, A; NILSSON, B; BJORKHOLM, M et al.Scandinavian journal of haematology. 1987, Vol 38, Num 2, pp 173-178, issn 0036-553XArticle

Low dose cyclophosphamide, alpha-interferon and continuous infusions of interleukin-2 in advanced renal cell carcinomaWERSÄLL, J. P; MASUCCI, G; MELLSTEDT, H et al.Medical oncology and tumor pharmacotherapy. 1993, Vol 10, Num 3, pp 103-111, issn 0736-0118Article

Biologic response modifiers in the treatment of gastrointestinal malignanciesMELLSTEDT, H; FRODIN, J.-E; OSTERBORG, A et al.Scandinavian journal of gastroenterology. 1989, Vol 24, Num 3, pp 257-268, issn 0036-5521Article

Therapeutic effects of low-dose cytosine arabinoside, alpha-interferon, 1α-hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromesHELLSTROM, E; ROBERT, K.-H; OST, A et al.European journal of haematology. 1988, Vol 40, Num 5, pp 449-459, issn 0902-4441Article